Maxwell Enterprises

Product Name: Mounjaro KwikPen Injection
Generic Name: Tirzepatide
Strength: 2.5 mg per dose
Dosage Form: Pre-filled Pen Injection
Packaging: Single pre-filled KwikPen (multi-dose; varies by market)
Manufacturer: Eli Lilly (brand owner)

Mounjaro 2.5 mg KwikPen contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes management and increasingly in weight management. The 2.5 mg strength is the starting dose, used to help patients gradually adapt to therapy before increasing to higher strengths.

Key Ingredient

Tirzepatide (2.5 mg)
Tirzepatide is an advanced dual-incretin therapy that activates both GIP and GLP-1 receptors, helping improve blood sugar control while significantly reducing appetite and body weight.

Indications

Mounjaro Injection is commonly used for:

• Type 2 Diabetes Mellitus
• Weight management / obesity (under medical supervision)
• Improving glycemic control and metabolic health

Mechanism of Action

Tirzepatide works by:

• Activating both GIP and GLP-1 receptors
• Increasing insulin secretion (glucose-dependent)
• Reducing glucagon release
• Slowing gastric emptying
• Suppressing appetite and reducing calorie intake

Directions for Use

• Administer once weekly via subcutaneous injection
• Inject into abdomen, thigh, or upper arm
• Start with 2.5 mg once weekly, then increase gradually
• Use on the same day each week

Additional Information:

• Delivery Time: 10-12 days

Product Name: Mounjaro KwikPen Injection
Generic Name: Tirzepatide
Strength: 5 mg per dose
Dosage Form: Pre-filled Pen Injection
Packaging: Single pre-filled KwikPen (multi-dose; varies by market)
Manufacturer: Eli Lilly (brand owner)

Mounjaro 5 mg KwikPen contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes management and weight management under medical supervision. This strength is typically used after the initial 2.5 mg starting dose as part of dose escalation to improve glycemic control and enhance weight-loss outcomes.

Key Ingredient

Tirzepatide (5 mg)
Tirzepatide is an advanced dual-incretin therapy that activates both GIP and GLP-1 receptors, helping improve blood sugar control, suppress appetite, and support significant weight reduction.

Indications

Mounjaro Injection is commonly used for:

• Type 2 Diabetes Mellitus
• Weight management / obesity (under medical supervision)
• Improving glycemic control and metabolic health

Mechanism of Action

Tirzepatide works by:

• Activating both GIP and GLP-1 receptors
• Increasing insulin secretion (glucose-dependent)
• Reducing glucagon release
• Slowing gastric emptying
• Suppressing appetite and reducing calorie intake

Directions for Use

• Administer once weekly via subcutaneous injection
• Inject into abdomen, thigh, or upper arm
• Use after the 2.5 mg starter dose as part of gradual escalation
• Use on the same day each week

Additional Information:

• Delivery Time: 10-12 days

Product Name: Mounjaro KwikPen Injection
Generic Name: Tirzepatide
Strength: 7.5 mg per dose
Dosage Form: Pre-filled Pen Injection
Packaging: Single pre-filled KwikPen (multi-dose; varies by market)
Manufacturer: Eli Lilly (brand owner)

Mounjaro 7.5 mg KwikPen contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes management and weight management under medical supervision. This intermediate strength is typically used after 5 mg as part of dose escalation to further improve glycemic control and support enhanced weight reduction.

Key Ingredient

Tirzepatide (7.5 mg)
Tirzepatide is a next-generation dual incretin therapy that activates both GIP and GLP-1 receptors, helping improve blood sugar control, suppress appetite, and support significant weight loss.

Indications

Mounjaro Injection is commonly used for:

• Type 2 Diabetes Mellitus
• Weight management / obesity (under medical supervision)
• Improving glycemic control and metabolic health

Mechanism of Action

Tirzepatide works by:

• Activating both GIP and GLP-1 receptors
• Increasing insulin secretion (glucose-dependent)
• Reducing glucagon release
• Slowing gastric emptying
• Suppressing appetite and reducing calorie intake

Directions for Use

• Administer once weekly via subcutaneous injection
• Inject into abdomen, thigh, or upper arm
• Use after 5 mg as part of gradual dose escalation
• Use on the same day each week

Additional Information:

• Delivery Time: 10-12 days

Product Name: Mounjaro KwikPen Injection
Generic Name: Tirzepatide
Strength: 10 mg per dose
Dosage Form: Pre-filled Pen Injection
Packaging: Single pre-filled KwikPen (multi-dose; varies by market)
Manufacturer: Eli Lilly (brand owner)

Mounjaro 10 mg KwikPen contains Tirzepatide, a dual GIP and GLP-1 receptor agonist used for type 2 diabetes management and weight management under medical supervision. This higher strength is typically used after gradual dose escalation to achieve stronger glycemic control and greater weight-loss support.

Key Ingredient

Tirzepatide (10 mg)
Tirzepatide is a next-generation dual incretin therapy that activates both GIP and GLP-1 receptors, helping improve blood sugar control, suppress appetite, and support significant weight reduction.

Indications

Mounjaro Injection is commonly used for:

• Type 2 Diabetes Mellitus
• Weight management / obesity (under medical supervision)
• Improving glycemic control and metabolic health

Mechanism of Action

Tirzepatide works by:

• Activating both GIP and GLP-1 receptors
• Increasing insulin secretion (glucose-dependent)
• Reducing glucagon release
• Slowing gastric emptying
• Suppressing appetite and reducing calorie intake

Directions for Use

• Administer once weekly via subcutaneous injection
• Inject into abdomen, thigh, or upper arm
• Use after proper dose escalation as prescribed
• Use on the same day each week

Additional Information:

• Delivery Time: 10-12 days

Product Name: Rybelsus Tablets
Generic Name: Semaglutide
Strength: 3 mg
Dosage Form: Oral Tablets
Packaging: 1 × 10 Tablets per Box
Manufacturer: Novo Nordisk (brand owner)

Rybelsus 3 mg Tablets contain Semaglutide, a GLP-1 receptor agonist used for the management of type 2 diabetes mellitus. This oral formulation helps control blood sugar levels and supports weight management. The 3 mg strength is typically used as an initial starter dose to help patients adjust to the medication before increasing to higher strengths.

Key Ingredient

Semaglutide (3 mg)
Semaglutide mimics the natural GLP-1 hormone, enhancing insulin secretion when blood glucose levels are elevated and reducing glucagon release. It also slows gastric emptying and reduces appetite.

Indications

Rybelsus Tablets are commonly used for:

• Type 2 Diabetes Mellitus
• Improving glycemic control in adults
• Supporting weight management as part of a treatment plan

Mechanism of Action

Semaglutide works by activating GLP-1 receptors, resulting in:

• Increased insulin secretion (glucose-dependent)
• Decreased glucagon secretion
• Slowed gastric emptying
• Reduced appetite and food intake

Directions for Use

• Take once daily on an empty stomach with a small amount of water (up to 120 ml).
• Take at least 30 minutes before food, beverages, or other medications.
• Swallow whole—do not crush or chew.
• Follow dose escalation as prescribed.

Additional Information:

• Delivery Time: 12-15 days

Product Description

Product Name: Rybelsus Tablets
Generic Name: Semaglutide
Strength: 7 mg
Dosage Form: Oral Tablets
Packaging: 1 × 10 Tablets per Box
Manufacturer: Novo Nordisk (brand owner)

Rybelsus 7 mg Tablets contain Semaglutide, a GLP-1 receptor agonist used for the management of type 2 diabetes mellitus. This strength is typically used as a maintenance dose after the initial 3 mg starting dose, helping achieve better blood glucose control and supporting weight management.

Key Ingredient

Semaglutide (7 mg)
Semaglutide mimics the natural GLP-1 hormone, enhancing insulin secretion, reducing glucagon levels, slowing gastric emptying, and decreasing appetite.

Indications

Rybelsus Tablets are commonly used for:

• Type 2 Diabetes Mellitus
• Improving glycemic control in adults
• Supporting weight management

Mechanism of Action

Semaglutide activates GLP-1 receptors, resulting in:

• Increased insulin secretion (glucose-dependent)
• Reduced glucagon release
• Slower gastric emptying
• Appetite suppression

Directions for Use

• Take once daily on an empty stomach with a small amount of water (up to 120 ml).
• Take at least 30 minutes before eating, drinking, or taking other medications.
• Swallow whole—do not crush or chew.
• Use as part of dose escalation (3 mg → 7 mg → 14 mg).

Additional Information:

• Delivery Time: 12-15 days

Product Name: Rybelsus Tablets
Generic Name: Semaglutide
Strength: 14 mg
Dosage Form: Oral Tablets
Packaging: 1 × 10 Tablets per Box
Manufacturer: Novo Nordisk (brand owner)

Rybelsus 14 mg Tablets contain Semaglutide, a GLP-1 receptor agonist used for the management of type 2 diabetes mellitus. This is the highest maintenance strength, typically prescribed after dose escalation (3 mg → 7 mg → 14 mg) to achieve optimal glycemic control and enhanced weight management benefits.

Key Ingredient

Semaglutide (14 mg)
Semaglutide mimics the natural GLP-1 hormone, helping regulate blood sugar levels by increasing insulin secretion, reducing glucagon release, slowing gastric emptying, and suppressing appetite.

Indications

Rybelsus Tablets are commonly used for:

• Type 2 Diabetes Mellitus
• Improving glycemic control in adults
• Supporting weight management

Mechanism of Action

Semaglutide activates GLP-1 receptors, leading to:

• Increased insulin secretion (glucose-dependent)
• Reduced glucagon secretion
• Slower gastric emptying
• Appetite suppression

Directions for Use

• Take once daily on an empty stomach with a small amount of water (up to 120 ml).
• Take at least 30 minutes before food, beverages, or other medications.
• Swallow whole—do not crush or chew.
• Use as prescribed after proper dose escalation.

Additional Information:

• Delivery Time: 10-12 days

We are a foremost exporter, distributor, wholesaler, trader, and supplier of an excellent quality Dinex Capsule. This Natclovir is formulated with quality proven chemical compounds by vendor’s pharmaceutical experts. As per the needs of our patrons, we are offering this Dinex Capsule in various packaging options. In order to make sure its exactness, this Natclovir is examined against various factors of quality by vendor’s quality controllers. Our patrons can take this Natclovir from us at nominal rates.

Features:

• Perfect composition
• Reliability
• Highly effective

 

Compositions: